- Sencure raises €5 million in Series A funding.
- The funding was led by Cottonwood Technology Fund, marking Sencure’s second funding round.
- Sencure is a health care startup that develops groundbreaking chips to measure electrophysiological parameters on the human body.
- This new funding brings Sencure’s total amount raised to €6.5 million.
Roden-based healthcare startup, Sencure, announced today that it has raised €5 million in a Series A funding round. With a mission to transform the health care industry, Sencure develops innovative chips that accurately measure electrophysiological parameters on the human body.
According to their Crunchbase profile, this recent round of funding, led by the Cottonwood Technology Fund, brings Sencure’s total funding to date to €6.5 million.
The accomplished young startup, based out of Roden, Drenthe in the Netherlands, plans to use the funds to continue pioneering in the health care and medical device industry. Aiming to take full advantage of the unprecedented advancements in technology across the globe, Sencure is fully committed to pushing the boundaries of what’s possible in health care technology.
With only two rounds of funding, this promising startup has gained valuable momentum. The noteworthy funding led by the Cottonwood Technology Fund empowers Sencure to continue its pursuit of advancing medical technology and positively impacting the health care industry.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!